TY - JOUR
T1 - A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1-2 and-3 in the European Prospective Investigation into Cancer and Nutrition (EPIC)
AU - Crowe, Francesca L.
AU - Key, Timothy J.
AU - Allen, Naomi E.
AU - Appleby, Paul N.
AU - Overvad, Kim
AU - Gronbaek, Henning
AU - Tjonneland, Anne
AU - Halkjaer, Jytte
AU - Dossus, Laure
AU - Boeing, Heiner
AU - Kroeger, Janine
AU - Trichopoulou, Antonia
AU - Zylis, Dimosthenis
AU - Trichopoulos, Dimitrios
AU - Boutron-Ruault, Marie-Christine
AU - de Lauzon-Guillain, Blandine
AU - Clavel-Chapelon, Francoise
AU - Palli, Domenico
AU - Berrino, Franco
AU - Panico, Salvatore
AU - Tumino, Rosario
AU - Sacerdote, Carlotta
AU - Bueno-de-Mesquita, H. Bas
AU - van Gils, Carla H.
AU - Peeters, Petra H. M.
AU - Gram, Inger T.
AU - Rodriguez, Laudina
AU - Jakszyn, Paula
AU - Molina-Montes, Esther
AU - Navarro, Carmen
AU - Barricarte, Aurelio
AU - Larranaga, Nerea
AU - Khaw, Kay-Tee
AU - Rodwell, Sheila
AU - Rinaldi, Sabina
AU - Slimani, Nadia
AU - Norat, Teresa
AU - Gallo, Valentina
AU - Riboli, Elio
AU - Kaaks, Rudolf
PY - 2011/3
Y1 - 2011/3
N2 - Background: Height and BMI are risk factors for several types of cancer and may be related to circulating concentrations of insulin-like growth factor-I (IGF-I), a peptide associated with increased cancer risk.Aim: To assess the associations between height, BMI and serum concentrations of IGF-I and IGF binding protein (IGFBP)-1, -2 and -3.Subjects and methods: This cross-sectional analysis included 1142 men and 3589 women aged 32-77 years from the multi-centre study, the European Prospective Investigation of Cancer and Nutrition (EPIC).Results: In men, there was a positive association between height and IGF-I; each 10 cm increment in height was associated with an increase in IGF-I concentrations of 4.3% (95% confidence interval (CI): 1.3-7.5%, p for trend = 0.005), but this association was not statistically significant for women (0.9%, 95% CI: -0.7 to 2.6%, p for trend = 0.264). In both men and women, the association between IGF-I and BMI was non-linear and those with a BMI of 26-27 kg/m(2) had the highest IGF-I concentration. BMI was strongly inversely related to concentrations of IGFBP-1 and IGFBP-2 in men and in women (p for trend for all <0.001).Conclusion: Height and BMI are associated with IGF-I and its binding proteins, which may be mechanisms through which body size contributes to increased risk of several cancers.
AB - Background: Height and BMI are risk factors for several types of cancer and may be related to circulating concentrations of insulin-like growth factor-I (IGF-I), a peptide associated with increased cancer risk.Aim: To assess the associations between height, BMI and serum concentrations of IGF-I and IGF binding protein (IGFBP)-1, -2 and -3.Subjects and methods: This cross-sectional analysis included 1142 men and 3589 women aged 32-77 years from the multi-centre study, the European Prospective Investigation of Cancer and Nutrition (EPIC).Results: In men, there was a positive association between height and IGF-I; each 10 cm increment in height was associated with an increase in IGF-I concentrations of 4.3% (95% confidence interval (CI): 1.3-7.5%, p for trend = 0.005), but this association was not statistically significant for women (0.9%, 95% CI: -0.7 to 2.6%, p for trend = 0.264). In both men and women, the association between IGF-I and BMI was non-linear and those with a BMI of 26-27 kg/m(2) had the highest IGF-I concentration. BMI was strongly inversely related to concentrations of IGFBP-1 and IGFBP-2 in men and in women (p for trend for all <0.001).Conclusion: Height and BMI are associated with IGF-I and its binding proteins, which may be mechanisms through which body size contributes to increased risk of several cancers.
KW - Body height
KW - body mass index
KW - insulin-like growth factor I
KW - insulin-like growth factor binding proteins
KW - obesity
KW - GROWTH-FACTOR-I
KW - BODY-MASS INDEX
KW - FACTOR BINDING-PROTEIN-3 CONCENTRATIONS
KW - BINDING-PROTEIN
KW - FACTOR (IGF)-I
KW - C-PEPTIDE
KW - INSULIN
KW - RISK
KW - WOMEN
KW - HORMONE
U2 - 10.3109/03014460.2010.507221
DO - 10.3109/03014460.2010.507221
M3 - Article
C2 - 20731527
SN - 0301-4460
VL - 38
SP - 194
EP - 202
JO - Annals of human biology
JF - Annals of human biology
IS - 2
ER -